Houssiau FA, Kirkove C., Asherson RA, Hughes Grv, Timothy ARMalgnant lymphoma in systemic rheumatic disease: report of five cases . Clin Exp Rheumatol1991; 9: 515-518.
2.
Hakulinen T. , Isomaki H., Knekt P.Rheumatoid arthritis and cancer studies based on linking nationwide registries in Finland. Am J Med1985; 78A: 29-32.
3.
Symmons Dpm.Neoplasms of the immune system in rheumatoid arthritis. Am J Med1985; 78A: 22-28.
4.
Hughes Grv, Elkon KB, Spiller R. et al. Polyarteritis nodosa and hairy cell leukemia. Lancet1979; 1: 678.
5.
Gabriel SE, Conn DL, Phyliky RL, Pittelkow MR, Scott REVasculitis in hairy cell leukemia: Review of the literature and consideration of possible pathogenic mechanisms. J Rheumatol1986; 13: 1167-1172.
6.
Fortin PRVasculitides associated with malignancy. Curr OpinionRheumatol1996; 8: 30-33.
7.
Greer JM, Longley S., Edwards NL, Elfenbein GJ, Panush RSVasculitis associated with malignancy. Experience with 13 patients and literature review. Medicine1988, 67: 220-230.
Raderer M., Scheithauer W.Postchemotherapy rheumatism following adjuvant therapy for ovarian cancer . Scand J Rheumatol1994; 23: 291-292.
10.
Rosman A., Atsumi T., Khamashta MA, Ames Prj, Hughes Grv.Development of systemic lupus erythematosus after chemotherapy and radiotherapy for malignant thymoma. Br J Rheum1995; 34: 1175-1176.
11.
Mevorach D. , Perrot S., Buchanan Nmm, Khamashta M., Laoussadi S., Hughes Grv, Menkes CJAppearance of systemic lupus erythematosus after thymectomy: four case reports and review of the literature. Lupus1995; 4: 33-37.
12.
Amft N., Papamichael D., Lister A., D'Cruz D.Connective tissue diseases developing after intensive chemotherapy for neoplasias of the immune system. (Submitted).
13.
Sperandio P. , Tomio P., Oliver Rtd, Fiorentino MV, Pagano F.Gonadal atrophy as a cause of thymic hyperplasia after chemotherapy. Br J Cancer1996; (In Press).
